Follow
Carmen Gomez-Guerrero
Carmen Gomez-Guerrero
IIS-Fundacion Jimenez Diaz. Autonoma University of Madrid
No verified email
Title
Cited by
Cited by
Year
Animal models of cardiovascular diseases
C Zaragoza, C Gomez-Guerrero, JL Martin-Ventura, L Blanco-Colio, ...
BioMed Research International 2011, 2011
5212011
Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation
L Rodríguez‐Mañas, M El‐Assar, S Vallejo, P López‐Dóriga, J Solís, ...
Aging cell 8 (3), 226-238, 2009
2672009
Suppressors of cytokine signaling abrogate diabetic nephropathy
G Ortiz-Muñoz, V Lopez-Parra, O Lopez-Franco, P Fernandez-Vizarra, ...
Journal of the American Society of Nephrology 21 (5), 763-772, 2010
2132010
Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte …
N Duque, C Gomez-Guerrero, J Egido
Journal of immunology (Baltimore, Md.: 1950) 159 (7), 3474-3482, 1997
1961997
Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities
L Opazo-Ríos, S Mas, G Marín-Royo, S Mezzano, C Gómez-Guerrero, ...
International journal of molecular sciences 21 (7), 2632, 2020
1912020
Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation.
C Gomez-Guerrero, MJ López-Armada, E González, J Egido
Journal of immunology (Baltimore, Md.: 1950) 153 (11), 5247-5255, 1994
1891994
Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy
S Rayego-Mateos, JL Morgado-Pascual, L Opazo-Ríos, M Guerrero-Hue, ...
International journal of molecular sciences 21 (11), 3798, 2020
1822020
Therapeutic approaches to diabetic nephropathy—beyond the RAS
B Fernandez-Fernandez, A Ortiz, C Gomez-Guerrero, J Egido
Nature Reviews Nephrology 10 (6), 325-346, 2014
1812014
Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis
O López-Franco, Y Suzuki, G Sanjuán, J Blanco, P Hernández-Vargas, ...
The American journal of pathology 161 (4), 1497-1505, 2002
1692002
Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis
G Ortiz-Munoz, JL Martin-Ventura, P Hernandez-Vargas, B Mallavia, ...
Arteriosclerosis, thrombosis, and vascular biology 29 (4), 525-531, 2009
1632009
Targeting inflammation in diabetic nephropathy: a tale of hope
JA Moreno, C Gomez-Guerrero, S Mas, AB Sanz, O Lorenzo, ...
Expert opinion on investigational drugs 27 (11), 917-930, 2018
1592018
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli
C Lorz, A Ortiz, P Justo, S Gonzalez-Cuadrado, N Duque, ...
Journal of the american society of nephrology 11 (7), 1266-1277, 2000
1552000
Parthenolide Modulates the NF-κB–Mediated Inflammatory Responses in Experimental Atherosclerosis
O López-Franco, P Hernández-Vargas, G Ortiz-Munoz, G Sanjuán, ...
Arteriosclerosis, thrombosis, and vascular biology 26 (8), 1864-1870, 2006
1402006
Roll of tumor necrosis factor-α in the pathogenesis of tlomerular disease.
J Egido
Kidney Int 43, S-59-S-64, 1993
1391993
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
N Gonzalez, I Prieto, L del Puerto-Nevado, S Portal-Nunez, JA Ardura, ...
Oncotarget 8 (11), 18456, 2017
1302017
Evidence for a specific IgA receptor in rat and human mesangial cells.
C Gomez-Guerrero, E González, J Egido
Journal of immunology (Baltimore, Md.: 1950) 151 (12), 7172-7181, 1993
1211993
Fcγ receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice
P Hernández-Vargas, G Ortiz-Munoz, O López-Franco, Y Suzuki, ...
Circulation research 99 (11), 1188-1196, 2006
1192006
Resolution of renal inflammation: a new role for NF-κB1 (p50) in inflammatory kidney diseases
U Panzer, OM Steinmetz, JE Turner, C Meyer-Schwesinger, C von Ruffer, ...
American Journal of Physiology-Renal Physiology 297 (2), F429-F439, 2009
962009
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension
S Blanco, M Vaquero, C Gómez-Guerrero, D López, J Egido, R Romero
American journal of hypertension 18 (4), 557-565, 2005
962005
Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches
C Gomez-Guerrero, P Hernandez-Vargas, O Lopez-Franco, ...
Current Drug Targets-Inflammation & Allergy 4 (3), 341-351, 2005
932005
The system can't perform the operation now. Try again later.
Articles 1–20